GITLAB INC. (GTLB) Spending and interest coverage
- R&D / revenue · 12 months: Value 28.82%; Formula and calculation Research and development expense / revenue. Period ending 2026-07-31..
- Stock-based compensation / revenue · 12 months: Value 21.79%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 28.82% | Research and development expense / revenue. Period ending 2026-07-31. $304.14M ÷ $1.06B × 100 ≈ 28.82% |
| Stock-based compensation / revenue · 12 months | 21.79% | Share-based compensation / revenue. Period ending 2026-07-31. $229.91M ÷ $1.06B × 100 ≈ 21.79% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 304.14M USD | Research and Development Expense |
| Revenue | 1.06B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 229.91M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -90.20M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $304.14M | $1.06B | $229.91M | $-90.20M | (m) | 28.82% | 21.79% | (m) | (m) |
| 2026-04-30 | $280.65M | $1.00B | $209.19M | $-51.62M | (m) | 27.93% | 20.82% | (m) | (m) |
| 2026-01-31 | $274.57M | $955.22M | $214.95M | $-70.48M | (m) | 28.74% | 22.50% | (m) | (m) |
| 2025-10-31 | $268.50M | $906.25M | $208.43M | $-84.66M | (m) | 29.63% | 23.00% | (m) | (m) |
| 2025-07-31 | $261.14M | $857.95M | $204.79M | $-101.03M | (m) | 30.44% | 23.87% | (m) | (m) |
| 2025-04-30 | $250.92M | $804.57M | $199.47M | $-123.69M | (m) | 31.19% | 24.79% | (m) | (m) |
| 2025-01-31 | $239.65M | $759.25M | $185.90M | $-142.72M | (m) | 31.56% | 24.48% | (m) | (m) |
| 2024-10-31 | $229.16M | $711.60M | $182.28M | $-158.26M | (m) | 32.20% | 25.62% | (m) | (m) |
| 2024-07-31 | $216.86M | $665.22M | $175.57M | $-169.79M | (m) | 32.60% | 26.39% | (m) | (m) |
| 2024-04-30 | $204.59M | $622.22M | $172.97M | $-182.85M | (m) | 32.88% | 27.80% | (m) | (m) |
| 2024-01-31 | $200.84M | $579.91M | $163.05M | $-187.44M | (m) | 34.63% | 28.12% | (m) | (m) |
| 2023-10-31 | $192.13M | $539.03M | $153.67M | $-198.83M | (m) | 35.64% | 28.51% | (m) | (m) |
| 2023-07-31 | $184.19M | $502.35M | $146.05M | $-215.53M | (m) | 36.67% | 29.07% | (m) | (m) |
| 2023-04-30 | $174.70M | $463.81M | $137.43M | $-226.77M | (m) | 37.67% | 29.63% | (m) | (m) |
| 2023-01-31 | $156.14M | $424.34M | $122.57M | $-211.41M | (m) | 36.80% | 28.88% | (m) | (m) |
| 2022-10-31 | $141.07M | $379.23M | $101.69M | $-205.69M | (m) | 37.20% | 26.82% | (m) | (m) |
| 2022-07-31 | $124.62M | $333.04M | $76.56M | $-181.27M | (m) | 37.42% | 22.99% | (m) | (m) |
| 2022-04-30 | $107.71M | $290.13M | $44.05M | $-145.80M | (m) | 37.12% | 15.18% | (m) | (m) |
| 2022-01-31 | $97.22M | $252.65M | $30.01M | $-128.96M | (m) | 38.48% | 11.88% | (m) | (m) |
| 2021-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-01-31 | $106.64M | $152.18M | $111.85M | $-213.88M | (m) | 70.08% | 73.50% | (m) | (m) |
| 2020-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-01-31 | $59.36M | $81.23M | $40.87M | $-128.37M | (m) | 73.08% | 50.32% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.